Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $59.7300 (-0.25%) ($59.4900 - $59.9100) on Mon. Aug. 7, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.93% (three month average) | RSI | 32 | Latest Price | $59.7300(-0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.3% a day on average for past five trading days. | Weekly Trend | BAX declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(58%) SPLV(53%) VYM(52%) IVE(50%) IWD(50%) | Factors Impacting BAX price | BAX will decline at least -0.465% in a week (0% probabilities). TLT(-19%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.465% (StdDev 0.93%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
Resistance Level | $61.2 | 5 Day Moving Average | $59.88(-0.25%) | 10 Day Moving Average | $60.39(-1.09%) | 20 Day Moving Average | $61.2(-2.4%) | To recent high | -5.3% | To recent low | 7.2% | Market Cap | $30.473b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |